3.8. Deacetylation of Mito-COX-2 via SIRT3 Activation Mediates Higher Sensitivity of HCC to Cisplatin by Inhibiting Mito-COX-2/p-Drp1Ser616 Interactions In Vitro and In Vivo. The gene discussed is SIRT3; the disease is hepatocellular carcinoma.